Imaging Hyperreflective Foci as an Inflammatory Biomarker after Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration Patients with Optical Coherence Tomography Angiography

Table 1

Baseline characteristics of patients with neovascular AMD and comparation of HRF in the SCP, DCP, and outer retina using OCTA between baseline and after the intravitreal anti-VEGF injections.

	M0	M3
Eyes (no.)	25	—	—
Sex (male/female)	15/10	—	—
Ages (years)		—	—
BCVA (logMAR)			<0.01
HRF-SCP (no.)			0.12
HRF-DCP (no.)			<0.01
HRF-outer retina (no.)			<0.01

Data are shown as a number or . Significant at . M0, baseline; M3, 3 consecutive monthly anti-VEGF injections. BCVA: best-corrected visual acuity; DCP: deep retinal capillary plexus; HRF: hyperreflective foci; Log MAR: the logarithm of the minimum angle of resolution; No. : number; SCP: superficial retinal capillary plexus; VEGF: vascular endothelial growth factor.